Landmark declaration to tackle AMR signed by 193 UN member states

21 September 2016
amr-big-2

A landmark declaration to combat the growing threat of antimicrobial resistance (AMR) has been signed by all 193 United Nations member states at a high-level meeting at the UN headquarters in New York.

The meeting brought together member states, non-governmental organizations, civil society, the private sector and academic institutions to address what has been described as “the greatest future threat to our civilization.”

Such is the threat, AMR is only the fourth health issue to trigger a UN general assembly meeting - HIV/Aids, non-communicable diseases and Ebola being the other three.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical